InsidersTradesSigma
Discover the full record of transactions filed by Shanafelt Armen, Director. Director active across 1 companies, notably Aeglea BioTherapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €788k. The latest transaction was disclosed on 9 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Armen Shanafelt is a Board Member at Aeglea BioTherapeutics, Inc. He plays an important role in the governance of the company, bringing his expertise in the biopharmaceutical sector. His involvement helps Aeglea focus on innovation and sustainable growth while navigating a constantly evolving environment.
